Inhibidor la alfa-1 proteinasa

Respreeza 5.000 MG Polvo y Disolvente Para Solucion Para Perfusion

50 mg/ml polvo y disolvente para solución para perfusiónSpainMarketedAuthorised 6 Nov 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RespreezaEuropean UnionAuthorised

Packs

Pack	Code	Status
RESPREEZA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial)	727262

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Inhibidor la alfa-1 proteinasa

Respreeza 5.000 MG Polvo y Disolvente Para Solucion Para Perfusion

50 mg/ml polvo y disolvente para solución para perfusiónSpainMarketedAuthorised 6 Nov 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RespreezaEuropean UnionAuthorised

Packs

Pack	Code	Status
RESPREEZA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial)	727262

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Inhibidor la alfa-1 proteinasa
Strength: 50 mg/ml
Dosage form: polvo y disolvente para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 6 Nov 2019
Registration: 1151006003
Marketing authorisation holder: Csl Behring Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/15/1006

Inhibidor la alfa-1 proteinasa · 4.000 mg · polvo y disolvente para solución para perfusión

Spain

Respreeza 1.000 MG Polvo y Disolvente Para Solucion Para PerfusionInhibidor la alfa-1 proteinasa · 1000 mg · polvo y disolvente para solución para perfusiónSpain

Respreeza 4.000 MG Polvo y Disolvente Para Solucion Para PerfusionInhibidor la alfa-1 proteinasa · 50 mg/ml · polvo y disolvente para solución para perfusiónSpain